---
figid: PMC2577794__3064fig1
figlink: /pmc/articles/PMC2577794/figure/F1/
number: Figure 1
caption: 'Uncovering cryptic genetic variation in C. elegans vulva development. (A)
  C. elegans vulva development. The invariant cell fate pattern (3°3°2°1°2°3°) is
  established through the interplay of three cell signaling pathways: Egf–Egfr–Ras,
  Delta–Notch, and Wnt–β-catenin. (B) Vulval precursor cell lineage. Letters indicate
  the division plane: (T) transverse (left–right), (L) longitudinal (anteroposterior),
  (U) undivided. The primary lineage is characterized by division of all four grandaughters
  in a transverse orientation. The secondary lineage (“LLTU” or “UTLL”) is characterized
  by an absence of division of one granddaughter and adhesion to the cuticle (underline).
  The tertiary lineage is a nonvulval fate, with a single division (“S”, fusion with
  the epidermal syncytium hyp7). The 3°3°2°1°2°3° pattern and Pn.p cell lineage are
  invariant in all wild isolates (except for P3.p division frequency) (). (C) Vulva
  signaling network showing the different Ras pathway components and the interplay
  between Ras and Notch pathways (see main text for description). (D) Schematic representation
  of invasive approaches to uncover cryptic genetic variation in the system. The graph
  shows a theoretical curve of the number of induced Pn.p cells (1° or 2° fate) as
  a function of EGF dose or Ras pathway activity; this number may range from 0 (no
  anchor cell) to 6 (egf overexpression). The plateau at the wild-type phenotype of
  three induced cells materializes robustness to some variation in the EGF signal
  or Ras pathway activity (; ). While N2, the reference C. elegans wild isolate, is
  located on the plateau under standard conditions, a second isolate (X) could be
  located at a different position on the plateau (stasis in the final fate pattern).
  Applying the same perturbation to both isolates will schematically shift their respective
  positions along the X-axis, thus uncovering an initially silent difference. As perturbations,
  we applied mutations in the Ras pathway (, ) and anchor cell ablations (). (gf)
  Gain of function; (rf) reduction of function.'
pmcid: PMC2577794
papertitle: Intraspecific evolution of the intercellular signaling network underlying
  a robust developmental system.
reftext: Josselin Milloz, et al. Genes Dev. 2008 Nov 1;22(21):3064-3075.
pmc_ranked_result_index: '199100'
pathway_score: 0.7251183
filename: 3064fig1.jpg
figtitle: Uncovering cryptic genetic variation in C
year: '2008'
organisms: Homo sapiens
ndex: 53160ff7-df25-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2577794__3064fig1.html
  '@type': Dataset
  description: 'Uncovering cryptic genetic variation in C. elegans vulva development.
    (A) C. elegans vulva development. The invariant cell fate pattern (3°3°2°1°2°3°)
    is established through the interplay of three cell signaling pathways: Egf–Egfr–Ras,
    Delta–Notch, and Wnt–β-catenin. (B) Vulval precursor cell lineage. Letters indicate
    the division plane: (T) transverse (left–right), (L) longitudinal (anteroposterior),
    (U) undivided. The primary lineage is characterized by division of all four grandaughters
    in a transverse orientation. The secondary lineage (“LLTU” or “UTLL”) is characterized
    by an absence of division of one granddaughter and adhesion to the cuticle (underline).
    The tertiary lineage is a nonvulval fate, with a single division (“S”, fusion
    with the epidermal syncytium hyp7). The 3°3°2°1°2°3° pattern and Pn.p cell lineage
    are invariant in all wild isolates (except for P3.p division frequency) (). (C)
    Vulva signaling network showing the different Ras pathway components and the interplay
    between Ras and Notch pathways (see main text for description). (D) Schematic
    representation of invasive approaches to uncover cryptic genetic variation in
    the system. The graph shows a theoretical curve of the number of induced Pn.p
    cells (1° or 2° fate) as a function of EGF dose or Ras pathway activity; this
    number may range from 0 (no anchor cell) to 6 (egf overexpression). The plateau
    at the wild-type phenotype of three induced cells materializes robustness to some
    variation in the EGF signal or Ras pathway activity (; ). While N2, the reference
    C. elegans wild isolate, is located on the plateau under standard conditions,
    a second isolate (X) could be located at a different position on the plateau (stasis
    in the final fate pattern). Applying the same perturbation to both isolates will
    schematically shift their respective positions along the X-axis, thus uncovering
    an initially silent difference. As perturbations, we applied mutations in the
    Ras pathway (, ) and anchor cell ablations (). (gf) Gain of function; (rf) reduction
    of function.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SOS2
  - SOS1
  - MAPK14
  - GRB2
  - ADCY3
  - MAPK13
  - ADCY10
  - NRAS
  - ARAF
  - MAPK9
  - MAP2K2
  - ADCY5
  - ADCY1
  - ADCY9
  - MAPK11
  - MAPK10
  - MAPK12
  - RAF1
  - BRAF
  - ADCY4
  - EGFR
  - PPFIA1
  - MAP2K1
  - ADCY2
  - MAPK8
  - ADCY6
  - MAPK1
  - MAPK3
  - NOTCH4
  - EGF
  - HRAS
  - ADCY8
  - NOTCH3
  - ADAM10
  - ADCY7
  - NOTCH1
  - KRAS
  - NOTCH2
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: so-1/Sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: so-1/Sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: MPK-1/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: SEM-5/Grb2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY3
  entrez: '109'
- word: MPK-1/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY10
  entrez: '55811'
- word: GAP-1HLET-60/Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: LIN-45/Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: MPK-1/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MEK-2/MEK
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY5
  entrez: '111'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY1
  entrez: '107'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY9
  entrez: '115'
- word: MPK-1/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MPK-1/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MPK-1/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: LIN-45/Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: LIN-45/Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY4
  entrez: '196883'
- word: LET-23/EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: LIP-1
  symbol: LIP.1
  source: hgnc_alias_symbol
  hgnc_symbol: PPFIA1
  entrez: '8500'
- word: MEK-2/MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY2
  entrez: '108'
- word: MPK-1/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY6
  entrez: '112'
- word: MPK-1/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MPK-1/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MEK-2/MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: LIN-12/Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH4
  entrez: '4855'
- word: LIN-3/EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: GAP-1HLET-60/Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY8
  entrez: '114'
- word: LIN-12/Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH3
  entrez: '4854'
- word: ADAM10
  symbol: ADAM10
  source: hgnc_symbol
  hgnc_symbol: ADAM10
  entrez: '102'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY7
  entrez: '113'
- word: LIN-12/Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH1
  entrez: '4851'
- word: GAP-1HLET-60/Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: LIN-12/Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH2
  entrez: '4853'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
